Author:
Alhalabi Omar,Rafei Hind,Bilen Mehmet Asim,Shah Amishi Yogesh
Publisher
Springer International Publishing
Reference249 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
2. Fisher R, Gore M, Larkin J, editors. Current and future systemic treatments for renal cell carcinoma. Elsevier, Chicago, IL, USA. Semin Cancer Biol 2013;23(1):38–45.
3. Howlader N, Noone A, Krapcho M, Miller D, Bishop K, Kosary C, et al. SEER cancer statistics review, 1975–2014. Bethesda: National Cancer Institute; 2017/2018.
4. Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results from a large, multicenter study. J Clin Oncol. 2009;27(34):5794–9.
5. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999;17(8):2530–40.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献